Survey data shows individuals are not informed on how COVID-19 could affect their conditions.
Jeremy Edwards
Advertisement
Articles by Jeremy Edwards
87% of people surveyed said they had no concerns about a decentralized approach to clinical trials.
Advertisement
Latest Updated Articles
- Recent Data Shows Positive Attitudes for Decentralized Trials in Rare Disease Patients
Published: November 13th 2020 | Updated:
Rare Disease Patients Overlooked During COVIDPublished: June 7th 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Bringing Clinical Trials Into the Digital Era with eConsent
2
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
3
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
4
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
